Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Mind Medicine Inc’s stock clocked out at $6.49, down -0.92% from its previous closing price of $6.55. In other words, the price has decreased by -$0.92 from its previous closing price. On the day, 0.75 million shares were traded. MNMD stock price reached its highest trading level at $6.6399 during the session, while it also had its lowest trading level at $6.46.
Ratios:
To gain a deeper understanding of MNMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.27 and its Current Ratio is at 7.27. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on January 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $23.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 25 ’25 when Sullivan Mark sold 11,491 shares for $6.80 per share. The transaction valued at 78,139 led to the insider holds 305,130 shares of the business.
Karlin Daniel sold 7,848 shares of MNMD for $53,366 on Jun 25 ’25. The Chief Medical Officer now owns 438,329 shares after completing the transaction at $6.80 per share. On Jun 25 ’25, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 26,491 shares for $6.80 each. As a result, the insider received 180,139 and left with 830,065 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 490340864 and an Enterprise Value of 299935712.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.83, which has changed by -0.067528725 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $10.44, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is -5.14%, while the 200-Day Moving Average is calculated to be -4.73%.
Shares Statistics:
It appears that MNMD traded 1.20M shares on average per day over the past three months and 1370440 shares per day over the past ten days. A total of 75.51M shares are outstanding, with a floating share count of 72.87M. Insiders hold about 3.55% of the company’s shares, while institutions hold 54.05% stake in the company. Shares short for MNMD as of 1749772800 were 11065859 with a Short Ratio of 9.24, compared to 1747267200 on 11497047. Therefore, it implies a Short% of Shares Outstanding of 11065859 and a Short% of Float of 14.760000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
